Dr Aung Pyae Phyo
Aung Pyae Phyo
Senior Clinican Scientist
Aung Pyae Phyo, a Burmese (Myanmar) Senior Clinican Scientist, finished medical training in 2001 in Yangon. He joined the Shoklo Malaria Research Unit in 2005 where he has led the cohort which unearthed the emergence of artemisinins resistance on the Thai-Myanmar border in 2010.
Afterwards, he pursued research on the Artemisinin Combination Therapy resistant malaria as well as the trials on the new antimalarial compounds such as OZ439 (Artefenomel), KAF156 (Ganaplacide) and KAE609 (Cipargamin).
In 2017 Aung Pyae Phyo completed his Doctor of Philosophy in Clinical Medicine at Oxford University. After completing the DPhil, he joined the Myanmar Oxford Clinical Research Unit in Yangon, Myanmar where his focus is malaria elimination and surveillance of the spread of drug resistant malaria in Greater Mekong Subregion (GMS).
In 2019 Aung Pyae Phyo received post-doctoral International Training fellowship from the Wellcome Trust to assess the immune decay after malaria elimination and the risk of malaria resurgence, and a seed grant from Australian Centre of Research Excellence in Malaria Elimination (ACREME) for the project Field evaluation of a point-of-contact device for P. falciparum malaria sero-surveillance
Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
van der Pluijm RW. et al, (2021), Lancet (London, England), 396, 1976 - 1977
Electrocardiographic effects of four antimalarials for pregnant women with uncomplicated malaria on the Thailand-Myanmar border: a randomised controlled trial.
Saito M. et al, (2021), Antimicrobial agents and chemotherapy
Serological evidence indicates widespread distribution of rickettsioses in Myanmar.
Elders PND. et al, (2020), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 103, 494 - 501
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
Imwong M. et al, (2020), The Lancet Infectious Diseases, 20, 1470 - 1480
Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Saito M. et al, (2020), BMC Medicine, 18